Pilot Study Differential Dissector™ for Blunt Dissection
1 other identifier
interventional
N/A
0 countries
N/A
Brief Summary
The primary purpose of this study is to evaluate the quality of blunt dissection during abdominal and pelvic surgery involving dissection of adhesions, separation of blood vessels and neurovascular structures while preserving the integrity of these structures.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Mar 2015
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2015
CompletedFirst Submitted
Initial submission to the registry
March 3, 2015
CompletedFirst Posted
Study publicly available on registry
March 9, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2016
CompletedAugust 5, 2016
July 1, 2016
1.3 years
March 3, 2015
August 3, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Operative Blood Loss
From start of surgery to wound closure
Post-operative Blood Loss
After surgical closure and drain insertion through drain removal
Study Arms (2)
Differential Dissector
EXPERIMENTALFor patients in the study device group, blunt dissection will be performed with the Differential Dissector whenever the surgeon believes its use is appropriate.
Standard Dissection Method
ACTIVE COMPARATORFor patients in the control group, blunt dissection will be performed by standard method.
Interventions
Eligibility Criteria
You may qualify if:
- Age greater than 18
- Patient will be undergoing open abdominal surgery
- Patient willing and able to provide his/her own consent
You may not qualify if:
- Current alcohol or other substance abuse
- Current incarceration
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Mark Koruda, MD
University of North Carolina, Chapel Hill
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 3, 2015
First Posted
March 9, 2015
Study Start
March 1, 2015
Primary Completion
July 1, 2016
Study Completion
July 1, 2016
Last Updated
August 5, 2016
Record last verified: 2016-07
Data Sharing
- IPD Sharing
- Will not share